text:
Cheap Stock Investor
Performance Record
Cheap Stocks, 4/5/2013 Update
Cheap Stocks, July 27, 2012 Update
We were up .8% last week and are now up 11.3% for the year.
Some of our stocks are just stupid cheap—compared to their net cash on hand per share divided by their stock price.
Check this list:
RIMG 88%
EXTR 47%
PTIX 69%
GRVY 100%
CCUR 65%
MTSL 44%
SIGM 64%
ASTX 49%
CTIG 60%
MRVC 66%
ANGN 42%
AVNT 69%
Plus, EXTR, RIMG, ANGN, SIGM and MRVC.PK are all in "play" with activist shareholders either trying to get them to pay out special dividends or take them over, or they are pursuing "strategic alternatives".
The DOW was up 2% last week, NASDAQ was up 1.1% and the Russell 3000 was up 1.6%.
LXK,RIMG, TSYS and SPNC earnings last week.
AVNW, CBEY, MTSL, GRVY, and MITL are our favorites.
For the year, the DOW is up 7%, NASDAQ is up 13.6%, and the Russell 3000 is up 9.8%
Last week we went 9 stocks up, 13 down and 2 unchanged. Since inception we are now 56 stocks up and 18 down for a 75.7% winning percentage (80% is our target win %).
Since our beginning, we have closed out the following positions:
2006-NTCT +44%
2006-ONXS +11% (Buyout offer)
2006-DTLK +41%
2006-CAW +21% (Buyout offer)
2007-IYXI.ob +44% (Buyout offer)
2007-MOBI +47% (Buyout offer)
2007-INFT +11% (Buyout offer)
2007-RITT +62%
2007-MIVA +55%
2007-DTLK +25% (2 weeks)
2007-PDLI + 3%
2007-QADI +25%
2007-CIMT +50%
2007-BDR +19%
2007-LINN.ob -57% (mortgage business bust didn't help here)
2007-TISA -39% (take some tax loss for 2007 due to disappointing results.
2008-ANGN +26%
2008-OPTO.ob +40% (Buy-out offer)
2008-PDLI +9% (company split, and special dividend)
2008-BDAY -39% (long overdue takeover offer-or "take-under")
2008-DTLK +40% (third trip on this one)
2008-ILOG +26% (Buy-out offer from IBM)
2008-PARL +56%
2009-MBRK +67%
2009-SNWL +14%
2009-CYNO +25%
2009-NED +46%
2009-CUTR +13%
2009-HSTM +67% (continued good earnings)
2009-RNWK +36%
2009-OPK +116%
2009-CLZR -32% (a loser even on a buy-out)
2009-DTLK +28% (our 5th profitable trip on this one)
2010-HPOL +110%
2010-DIVX +25%
2010-CHRD +37% Buyout (2 weeks after we recommended it)
2010-HPOL +30%
2010-MGIC +82%
2010-GSL +78%
2010-CCEL +49%
2010-CAW EVEN (excluding 2.5 years of dividends)
2011-DWCH +116%
2011-IPAS +15%
2011-PRM +56% Buyout (1 week after we recommended it)
2011-RST +12%
2011-NINE -10%
2012-BVSN +30%
2012-TISA +137%
The model portfolio assumes $10,000 invested in each stock (unless we double-up–then it is $20,000), less $10 commission each way (TD Ameritrade rate).
For the 50 stocks that we closed out since 2006 (45 were winners) the average net gain was 38%.
Telecommunications Systems Inc. (NASDAQ-AVNW)-Recommended 6/14/2012)
Buy Price- $1.37
NEW Valuation $6.72 (Was $5.49)
Closed up $.11 at $1.36
Earnings announced last week. They were fine. Revenues were up 14% to $114 million and cutting through all the goodwill write-off it looks like they made $1.5 million on an operating basis. Our valuation rose to $6.72. After falling to around $1.15 the stock popped back up to close at $1.36 when it became apparent the sky was not falling.
A $11 million contract extension was announced last week.
TSYS announced an acquisition on in July. They are buying the leader in 911 communications for $37 million.
Down 1%, BUY
Aviat Networks Inc. (NASDAQ-AVNW)-Recommended 2/27/2012)
Valuation $8.85 (Was $8.31)
Closed down $.38 at $2.22
The stock dropped on no news. But so did SPNC and TSYS before earnings for no reason and then popped back quickly. Let's hope we have the same case here.
Earnings out in May. Revenues were down $4 million to $111.6 million, but they made $2.2 million on a Non-GAAP basis versus losing $.4 million last year.
Our valuation rose to $8.85 and cash per share rose to $1.53.
Down 15%, BUY
CBeyond Inc. (NASDAQ-CBEY)-Recommended 2/28/2012)
Buy Price $7.17- ( Was $7.94 before another $10,000 added at $6.53)
Valuation $29.58 (Was $29.21)
Next earnings due out on Wednesday, August 1st after the market close.
Earnings out in May Revenues were up $5 million to $124 million and they lost $1.2 million versus $.14 million last year. EBITDA was up $4 million to $23 million. We continue to think this is way undervalued and are adding another $10,000 here.
Our valuation inched up to $29.58.
Up 1%, BUY
MRV Communications (Pink Sheets-MRVC.pk)
Valuation $1.73 (Was $2.06, $2.16 (after $.475 and $.30 special dividends), $2.62, $2.79)
Buy Price October 7, 2011- $.50 ($1.27 before special dividends)
Closed at $.59 down $.07
MRV announced that they had settled a lawsuit related to a past acquisition and will pay $2.3 million, but get a $2.2 million gain this quarter as the settlement was less than they had booked.
The $.30 special dividend was paid in June
Raging Capital continues to buy shares. They now own over 27 million shares or 17.6% of MRV.
Earnings announced in May. All numbers have been restated for the CES sale in Q1.
Sales fell from $53 million to $48 million and the lost about $3.5 million pre-tax (after taking out stock compensation and a CFO severance charge). MRV declared another special dividend last week. $.30 a share this time. This will leave them with about $47 million of cash or another $.29 a share. Our valuation fell to $1.73 per share. Cash was $.59 per share. After the special dividend payable this month, our adjusted valuation will be $1.43 and assuming the stock price falls by the same amount, the stock will be trading at about 50% of our valuation.
Up 8% HOLD
Sigma Designs Inc. (NASDAQ-SIGM)-Recommended 7/11/2011)
Buy Price-$8.49
Valuation $10.67 (Was $8.41 $12.10, $13.40, $16.02)
Sigma and Potomac continue their war of words as Potomac wants Board seats and Sigma is fighting. More letters to shareholders and phone calls.
Good news, SIGM terminated its shareholder rights agreements and named a new Chairman of the Board. Maybe they are clearing the way to be sold?
Earnings announced in May. Still losing money but sales were up to $40 million from $36 million last quarter. They lost $8.5 million on a non-GAAP basis versus $14 million last quarter. Net cash per share fell a bit to $4.32. Over all our valuation increased about 25% to $10.67. Not bad, but not good enough to buy any more here.
They are projecting sales for next quarter (Q2) to be between $61-$67 million with 45% GAAP margins. Operating breakeven is expected in Q4 including the Trident acquisition which is expected to contribute about $24 million of sales per quarter.
So we are trading at a market cap of about $70 million (excluding cash) for a $$200 million a year chip company with 50% margins. Still pretty stupid we think. We plan to hold on for another couple of quarters to see if they can turn this around.
Down 21%, HOLD
Mitel Networks (NASDAQ-MITL)-Recommended 7/6/2011)
Buy Price- $3.04( Was $3.36 before $10,000 added, $3.95 before $10,000 added)
Valuation $13.92 (Was $12.81, $15.28, $14.04, $10.39)
Earnings announced in June. Another very good quarter. Sales were up about 4% to $158 million and they made $17.1 million of income on a Non-GAAP basis. Our valuation rose to $13.92. MITL appears to be running on all eight cylinders now.
Up 42%, BUY
Rimage (NASDAQ-RIMG)-Recommended 5/24/2011)
Buy Price-$14.20
NEW Valuation $$14.03 (Was $19.81, $22.23, $25.63, $26.45)
Pays $.68 a share annual dividend.
We have collected $.54 of dividends since we recommended RIMG.
Earnings last week. Well not really earnings. Revenues fell 9% to $18.3 million, margins fell to 45% from 49% last year and they lost $2.75 million or $.27 per share. Qumu revenues were a whopping $1.4 million. Cash fell to $62.3 million or $6.13 and our valuation fell again to $14.03
This is the worst case of management squandering its assets on an acquisition to escape being bought out and fired. We have lost over $12 on our valuation and the stock is down over 50% Spent over $40 million to buy Qumu's paltry revenue stream.
They are now projecting next quarter to be $20-$22 million of revenue and only lose $.02-$.10 per share. Guidance for 2012 is low double digit sales growth and the same level cash flow.
Teetering on selling here despite the yield.
Lexmark International (NYSE-LXK)-Recommended 5/24/2011)
NEW Valuation $70.28 (Was $62.59, $63.94, $63.84, $79.12, $63.99)
Closed down $2.33 at $17.33
We have also collected $.80 a share in dividends here.
LXK now pays a $1.20 annual dividend.
Earnings announced last week. Revenue fell 12% and Non-GAAP earnings fell to $.89 a share from $1.36 a year earlier. Currency and Europe were blamed for the shortfall. Q3 guidance is another 10% revenue decline and Non-GAAP earnings of $.75-$.85 compared to $.95 last year. Our valuation actually increased on a gross margin increase to $70.28 and net cash fell a bit to $3.85 a share as they bought back 800,000 shares for $25 million and paid their quarterly dividend. This is why we don't like Wall Street analysts. They would rather pay 100 times earnings for some maybe good company than a proven cash machine like LXK. Yield is now 6.9%
They reiterated their intent to return over 50% of their free cash flow to shareholders in dividends and share repurchases. The vagaries of the stock analysts make us cautious but we are back down well below our original buy price so we are making this a Buy again.
MER Telemanagement (NASDAQ-MTSL)-Recommended 5/17/2011)
Buy Price-$1.42 (Was $1.50 before adding another $10,000 investment)
Valuation $5.77 (Was $5.55, $6.28 $5.61, $5.11)
Earnings announced in May. Sales were up from $2.8 million to $3 million and they made $.07 per share versus $.03 last year. With $.80 a share in cash, this is trading at about 4X annualized earnings. Way too cheap. Our valuation rose to $5.77 per share.
Up 30% BUY
Harris Interactive (NASDAQ-HPOL)-Recommended 3/3/2010)
Buy Price-$.92
Valuation $3.15 (Was $3.05, $2.90, $3.11, $2.63, $2.97)
Closed at $1.18, up $.10
Earnings announced in May. Sales dropped $3 million from $37 million to $34 million. Their loss was slashed from $2.3 million to $.3 million. Not bad. Our valuation rose to $3.15 per share. If they can get some sales momentum over the next couple of quarters we could see $2 plus. If……..
EVP purchased 12,500 shares in March at $1.03 and interim CFO bought 11,000 shares at $1.02.
Up 28%, HOLD
Concurrent Computer (NASDAQ-CCUR)-Recommended 2/4/2011)
Valuation $15.85 (was $14.13, $11.38, $14.04, $18.54, $15.99)
CCUR took on two of the Singer/Miller Board nominees and entered into a standstill agreement until the 2012 Shareholders meeting.
CCUR announced the initiation of a quarterly dividend of $.06 or $.24 annually in July.
Another 13D filed in June by what looks like another disgruntled shareholder (Stephen D. Baksa). Owns 435,000 shares or 5%.
13D/A filed in June disclosing another 100,000 shares purchased on June 13th by the Singer/Miller group for $3.75. Their combined ownership is now 11.7%.
Singer is also involved in MRV and was involved with Evolving Systems (which we owned personally even though we didn't recommend it—it was a huge winner).
Earnings announced in May. Not bad. Revenues were down $2 million to $16.3 million but they made $.04 per share. Cash fell to $2.61 per share as receivables rose. Our valuation rose to $15.85, the second quarter of rising valuation and just about back to when we recommended it. Now the price just needs to reflect the improvement.
Astex Pharmaceuticals Inc. (Was SuperGen Inc.) (NASDAQ-ASTX)-Recommended 10/4/2010)
Buy Price-$2.31 (was $2.09 before adding $10,000)
Valuation $3.44 (was $3.42, $3.22, $3.11, $5.21, $4.89, $4.37, $3.48)
Next earnings due out Monday July 30th, after the market close.
ASTX rallied earlier in July as they announced that Janssen-Cilag International NV was notified that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) granted a positive opinion recommending approval of DACOGEN(R) (decitabine) for Injection in the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukemia (AML), according to the World Health Organization (WHO) classification who are not candidates for standard induction chemotherapy. Janssen is the licensee for DACOGEN in territories outside of the United States, Canada and Mexico.
Earnings announced in May. Pretty good. Cash was $1.21 per share. Revenues spiked to $22 million from $17 million last year and they made $.04 per share on a GAAP basis compared to $.09 last year. They are still forecasting $65- $68 million in revenues for the year and losing $13-$15 million on a GAAP basis. Cash burn looks like about $5 million for the year.
So we have a company losing maybe $5 million in cash a year, or 25 years of cash, about $70 million in revenues and a huge drug pipeline. Any good news on the clinical trials front ought to set this stock on fire.
As we said before, the merger with the revenue poor Astex hurt our valuation which does not take into account the massive drug pipeline of Astex. It is not easy to find a small drug company that has a pile of cash, is not losing a ton of money and is trading at even close to our valuation.
There are $2 BILLION of potential milestone payments down the road.
Up 7%, HOLD
Performance Technology (PTIX-Recommended 3/30/2010)
Valuation $6.01-(was $6.17, $5.94, $4.87, $4.99, $3.79, $3.87, $5.03, $5.98, $7.13)
PTIX announced a sales win in Azerbaijan in July.
Earnings announced in May. Sales were down to $8.4 million from $9.7 million last year, but they made money this year, $.03 a share versus a loss of $.10 last year. Margins expanded to 55% and cash and investments were $1.40 per share. Our valuation fell to $6.01. Still trading at 38% of our valuation and has 60% of its market cap in cash.
Extreme Networks (EXTR-Recommended 3/22/2010)
Buy Price-$3.18 (Was $3.04 before adding another $10,000)
Valuation-$6.31 (was $7.01, $6.72, $6.45, $5.67, $7.36, $7.23, $7.31, $6.82, $6.81)
Closed at $3.41 up $.19.
Next earnings due out Wednesday, August 1st, after the market closes.
Earnings announced in May. Sales fell to $73.4 million from $75.7 million, but they earned $2.3 million versus a $6.8 million loss last year. Cash per share stayed at $1.56 and our valuation fell to $6.31 on the sales decline. They are projecting next quarter at sales of $82-$90 million and EPS over $.10.
Starboard owns 9.7%, Soros 8.8% and Blackrock owns 5.5% of EXTR.
Gravity Company Ltd. (GRVY-Recommended 1/18/2010)
Buy Price- $1.45 per ADS (Was $1.68 before double up)
Valuation $5.52-(Was $5.00, $5.39, $5.33, $5.61, $5.73, $4.38, $4.44, $5.15)
Now trading at cash value again.
Q1 earnings announced in May. Nice. Revenues were $14.4 million and they made $1 million or $.04 per ADS. Cash was $48 million or $1.74 per share. No update on how Ragnarok 2 was doing or rumored Face Book games. Short term holders were disappointed as the stock fell. We are thrilled that cash and revenues went up from last quarter and our valuation rose to $5.52.
Ragnarok was commercially released in Korea on March 26th.
AEterna Zentaris (AEZS-Recommended 6/20/2009)
Buy price $1.42 (was $1.78 before adding another $10,000, $1.82 before double up)
Valuation –Speculation.
AEZS announced that Perifosine failed in April. Carnage followed. Hmm, this will teach us a lesson to not recommend speculations any more. We are still holding ours as a lottery ticket.
Earnings out in March. Revenues for the quarter were $12.6 million, up from $10 million last year. Net loss was $7.5 million compared to $6.6 million last year. The net loss for the year was $29 million. Cash stood at $47 million and they continue to sell more stock. They sold another 3.6 million in 2012 so far and raised $6.4 million.
Speculative for sure.
Spectranetics (SPNC-Recommended 9/2/2006)
Buy price $5.68 (was $8.90, $9.40 before adding $10,000, and was $10.65 before double up),
Valuation –$16.00 (was $14, $12, $10)
Earnings last week. Well it appears they did not screw anything up and the stock rebounded to hit a new high of $12.14. Sales were up 9% YOY and they made $.02 a share (same as last year). They did raise annual guidance to 8-10% revenue growth versus 5-7% previously. The stock seems like it wants to go higher.
A Board member bought 6,000 shares on May 25th, at just over $9.90. Good show of support at this level.
This company needs to be sold so that someone can take advantage of their 70%+ gross margins and enjoy some profits.
Up 111%, HOLD
Mediware (MEDW-Recommended 6/4/2007)
Buy Price $6.33, (was $6.52, $6.67 ($10,000 added), $6.98 after double up)
Valuation $19.24 (was $18.15, $17.96, $18.34, $16.07, $15.04, $14.23, $15.02, $14.35, $12.13, $12.57, $12.29, $11.90, $11.30, $11.48, $11.47 $10.99, $10.28, $13.32, $12.89, $13.40)
Closed down $.36 at $13.55
Earnings announced in May. Another good report. Revenues increased 22% and they made $.22 per share compared to $.17 last year. Cash is closing in on $4.50 a share ($4.42). Our valuation rose to $19.24.
All we read is that medical records will be a hot area, so MEDW looks like the place to be.
Inuvo (INUV (was-VTRO, MIVA)-Recommended 10/21/2007)
Buy Price $8.15 (Was $11.90 before adding another $20,000, $13.10 before another $10,000 and was $15.00 before double up),
Valuation $1.84 (was $8.04, $10.91, $12.42, $14.23, $14.76, $12.40, $12.55, $10.85, $8.25, $9.45, $28.05, $32.10, $34.20, $37.90, $37.95)
Earnings announced in May. The quarter only contained 1 month of combined operations after the merger. Sales for the quarter were $8.8 million and they reported $.2 million of adjusted EBITDA. The actual loss was $1.8 million. Our valuation plummeted to $1.84 a share based on the reported numbers. Our "guesstimate" valuation for a full quarter of combined operations is $3.59.
Down 90% HOLD
Angeion Corporation (ANGN-Recommended 8/28/2008)
Buy Price-$3.82 (was $5.15 before $10,000 added)
Valuation $11.95 (was $13.36 $15.90, $13.13, $13.19, $13.60, $15.00, $13.06, $12.15, $11.29, $11.73, $11.47, $11.16, $9.53, $13.30, $13.03)
The CEO bought 3,400 shares at $5.73 on June 13th.
Earnings announced in June. Hmmm. Sales were down from $6.8 million last year to $6.3 million. They lost $.4 million versus $.1 million last year. Not great, but they blamed it on a few large customers pushing out some orders into the current quarter. We'll see soon, cause then this quarter should be a barn burner. Our valuation slipped to $11.95 ($13.19 last year). Cash was $2.45 per share versus $2.42 last quarter. They also disclosed that they had entered into a Letter of Intent (LOI) to sell their New Leaf business and were going to change their name to MGC Diagnostics Corporation. Well at least that sounds like a medical company.
If this company could just show a bit of growth I think we would see $10 in short order—if.
Blueline Partners still owns 7.6% of ANGN and ought to be pushing on the company to do something about the stock price.
While ANGN is still trading at less than ½ our valuation, we are switching to a HOLD until we gets some results or news that improves the prospects here.
OB-abies (Bulletin Board Listed Stocks)
As proven by OPTIO, patience is necessary with these stocks.
ARI Networks (ARIS.ob-Recommended 8/19/2006)
Buy price $1.61 (Was $1.78 before another $10,000 added, was $2.06 before double up),
Valuation $6.13 (was $5.82, $5.81, $5.72, $5.65, $5.39, $4.86, $5.60, $5.73, $5.54, $5.74, $5.96, $4.72, $5.19, $5.66, $5.63, $5.61, $5.71, $5.49, $5.34, $5.03, $5.28, $5.28, $5.21)
Closed at $1.10 unchanged.
Earnings announced in June. Not bad. Sales were up 7% to $5.7 million and they made $.03 a share down from $.07 last year as they spent more on technology infrastructure, investor relations and product development.
Our valuation moved up to $6.13—the highest ever since we have been following the stock. No one cared as the stock didn't trade after the earnings announcement. Looks like they need to even spend more on investor relations and PR.
Now down 32%, BUY, Still a Huge valuation gap here.
Rand Worldwide (RWWI.ob (Was Avatech, AVSO.ob)-Bought November 28, 2005)
Buy price $.79 (Was $.93, $.99 and $1.19 before adding $10,000-each time),
Valuation $2.55 (was $2.08, $2.09, $2.12, $2.60, $2.40, $1.90, $2.26 $3.07, $3.03, $2.38, $2.57, $2.81, $2.78, $3.30, $3.76, $4.00 $3.41, $3.05, $2.53, $3.25, $3.29 $2.69, $3.36, $3.81)
Stock closed at $.70, down $.14
Earnings announced in May. Not bad. While sales were down to $22 million from $27 million last year (last year included a one big order), they made $.03 a share compared to $.04 last year. Margins increased to just over 50% from 47% last quarter. Our new valuation is $2.55 a share, down $.05 from last year.
Peter Kamin the new Chairman of the Board filed a 13d in March disclosing an 11% ownership state. Interesting as one would file a 13G if their intention was to just be a passive investor. Maybe as Chairman he will do SOMETHING to get the share price up.
RWWI announced an acquisition in March, but gave no financial details. "If a tree falls in the forest but there is no one around to hear it, dies it make a sound"? Seems like the company is making no effort to get this company known to the investment community. We have been in this one a LONG time and are getting impatient.
Market cap of $41 million for a $90 million in sales company with 50% margins and not losing money, just too cheap.
Our valuation is 3X the current price.
CTI Holdings (CTIG.ob-Recommended 2/25/2006)
Buy price $.27 ask,
Valuation $1.34 (Was $1.37, $1.36, $1.23, $.91, $1.21, $.71, $.83, $.88 $.96, $.93, $.75, $.85, $1.57, $1.40, $1.29, $1.38, $1.31, $1.38, $1.29, $1.42, $1.28 $1.13, $1.05, $.82)
Ask price $.21 closed at $.19.
CTIG announced a product deal with Mitel in June. Any PR is good news here.
A Director purchased 30,000 shares on May 23rd at $.25 a share. Not a lot of money but a good sign that things are going well.
Earnings announced in May. Sales were up $250k over last year to $4.4 million and they made $113k versus a loss of $342k last year. Cash rose to $3.7 million or $.13 per share. Our valuation fell $.03 to $1.34 but this is up from $.91 a year ago. Three profitable quarters in a row.
At an $8 million market cap, this is stupidly cheap. Their intellectual property is probably worth 3 times this price. They need to liquefy this value somehow.
Still an "undercover" company and stock.
Down 22%. BUY
Lotus Pharmaceuticals (LTUS.ob-Recommended 12/3/2007)
Buy price $1.68 (Was $1.80 before $10,000 adder, $2.16 before double-up)
Valuation-$.85 (Was $1.05, $2.43, $4.11, $4.84, $4.98, $4.60, $3.82, $4.00, $3.68, $3.12, $3.98, $4.44, $3.22, $2.12, $4.56, $4.16)
Closed at $.04, unchanged.
Now LTUS announced in April that they have no money for audits and SEC filings. Hammered down to less than a nickel a share. Can you spare them some money? Not worth selling at this point until we need tax losses. Maybe something good will happen. What a disaster. No more Chinese stocks for us, no matter how compelling the valuation.
Earnings announced in November. Revenues were up slightly over last year at $19 million versus $18.3 last year, but gross margins remained low and they made $2.1 million of $.04 per share compared to $.25 last year. Our valuation fell again to $.85.
Dave O
Cheap Stocks, 7/20/2012 Update
We were down 3.7% last week and are now up 10.5% for the year. Only RIMG had bad news and that was down 7%.
GRVY 99%
The DOW was up .5% last week, NASDAQ was down .6% and the Russell 3000 was up .2%.
For the year, the DOW is up 4.4%, NASDAQ is up 11.6%, and the Russell 3000 is up 7.9%
Valuation $5.49
Next earnings due out July 26th after the market close.
TSYS announced in June that they were writing off $126 million of goodwill. No cash impact to this although they will show a big loss for Q2.
Closed at $.66 up $.04
Up 13% HOLD
Valuation $$19.81 (Was $22.23, $25.63, $26.45)Closed up $.54 at $7.47
RIMG announced they would miss this quarters guidance on both the revenue and income side. Seems that this was priced in as the stock didn't plummet.
Another lousy quarter. Sales down 9% to $19.5 million and they lost $3 million on an operating basis. Cash fell to $66.8 million or $6.52 and our valuation fell again to $16.73.
This is the worst case of management squandering its assets on an acquisition to escape being bought out and fired. We have lost almost $10 on our valuation and the stock is down almost 40%. Qumu sales were $1.4 million. Spent over $40 million to buy this paltry revenue stream.
Guidance for 2012 is low double digit sales growth and the same level cash flow. Teetering on selling here despite the yield.
LXK upped their dividend to $.30 a quarter.
LXK warned in July and the stock got hammered. Earnings for the June quarter are projected to be $.87 to $.89 instead of the $.95-$1.05 previously guided. Revenues are expected to be down 12% YOY compared to the 7-9% previously guided. Europe and currency translation were cited as the reasons. They expect these factors to continue for the rest of the year. They will issue new guidance for the year in their earnings call on Tuesday, July 24th.
The stock lost 25% of its market cap on this. The dividend yield is now 5.9%.
Earnings announced in April. Revenues were $992 million and they made $1.05 per share on a non-GAAP basis. Net cash fell to $4.31 per share due to acquisitions, dividends and stock buybacks of $260 million. Fully diluted shares outstanding were 72.3 million compared to 79.8 million when we recommended LXK. Our valuation fell to $62.59. Analysts were disappointed, so down went the stock.
Closed at $1.08, down $.04
CCUR announced the initiation of a quarterly dividend of $.06 or $.24 annually in July. Whoo, Hoo. With all these vultures circling, they figured they had better do something. Feeble attempt we think.
ASTX rallied on Friday as they announced that Janssen-Cilag International NV was notified that the Committee for Medical Products for Human Use (CHMP) of the European Medicines Agency (EMA) granted a positive opinion recommending approval of DACOGEN(R) (decitabine) for Injection in the treatment of adult patients (age 65 years and above) with newly diagnosed de novo or secondary acute myeloid leukemia (AML), according to the World Health Organization (WHO) classification who are not candidates for standard induction chemotherapy. Janssen is the licensee for DACOGEN in territories outside of the United States, Canada and Mexico.
Closed unchanged at $2.01
PTIX announced a sales win in Azerbaijan last week.
Valuation –$14.00 (was $12, $10)
No news to account for the plunge last week. SPNC had been holding strong.
Next earnings due out Thursday, July 26th before the market opens.
Earnings announced in May. Sales up 10% to $33.3 million and they broke even. Gross margins improved to 73%. SPNC also received FDA approval on the GlideLight laser Sheath which makes it easier to extract pacemaker leads.
Guidance for 2012 is unchanged– a 5-7% increase in revenues and $.04-$.08 in earnings per share, excluding two new product introductions anticipated for mid year introductions.
Closed at $1.10 down $.15
Oiy! Lotus announced in January that they had "sold" their Mongolian land. They get nothing for it and give up 3 drugstores in Bejing and $7 million of receivables. Not good as reflected on the huge (percentage wise at least) drop in the stock. This has indeed become a cheap lottery ticket. 25 shares for a buck. We are licking our wounds on this one, but will just wait it out. It may go to $0, or may hang around in the penny stock range for a while. The move into the new building has commenced and the warehouse (supposedly critical to selling in Bejing) will be functional by March and production to start by September.
We were down 1.2% last week and are now up 14.2% for the year
The DOW was down .1% last week, NASDAQ was down 1% and the Russell 3000 was even..
Last week we went 7 stocks up, 15 down and 2 unchanged. Since inception we are now 57 stocks up and 17 down for a 77% winning percentage (80% is our target win %).
TSYS announced an acquisition on Friday. They are buying the leader in 911 communications for $37 million.
Valuation $$19.81 (Was $22.23, $25.63, $26.45)
LXK warned last week and the stock got hammered. Earnings for the June quarter are projected to be $.87 to $.89 instead of the $.95-$1.05 previously guided. Revenues are expected to be down 12% YOY compared to the 7-9% previously guided. Europe and currency translation were cited as the reasons. They expect these factors to continue for the rest of the year. They will issue new guidance for the year in their earnings call on Tuesday, July 24th.
They reiterated their intent to return over 50% of their free cash flow to shareholders in dividends and share repurchases. The vagaries of the stock analysts make us cautious but we are back down below our original buy price so we are making this a Buy again.
Down 2%, HOLD
Closed at $3.22 down $.22.
Closed up $.39 at $11.78
Stock closed at $.85, up $.01
Down 7%. BUY
We were down 1% last week and are now up 15.4% for the year
The DOW was down .8% last week, NASDAQ was up .1% and the Russell 3000 was down .3%.
AVNW, CBEY, MTSL, GRVY, LXK and MITL are our favorites.
For the year, the DOW is up 4.5%, NASDAQ is up 12.8%,, and the Russell 3000 is up 7.9%
Closed at $.66 unchanged
Sigma and Potomac continue their war of words as Potomac wants Board seats and Sigma is fighting.
Closed at $1.13, unchanged
CCUR announced the initiation of a quarterly dividend of $.06 or $.24 annually. Whoo, Hoo. With all these vultures circling, they figured they had better do something. Feeble attempt we think.
Now trading at just above cash value again.
Stock closed at $.84, unchanged
CSI Update, December 2019, Private Subscribers
CSI Update, December 2019, Free Blog
CSI Update, November 2019-Private Subscribers
CSI Update, November 2019-Free Blog
CSI Update, August 2019-Private Subscribers
Johns Gmail on CSI Update, December 2019, Pri…
Alessandra Torresani… on 74% gain today
Dave O on 74% gain today
agetcartoonhdapp.com on 74% gain today
Cheap Stock Weekly Update
CSI Tip
CSI Update


text:
148 adjunct professor jobs found
United States (132) Singapore (9) Australia (3) China (2) Canada (1) Sweden (1)
California (76) New York (28) Washington (16) Illinois (5) Ohio (4) New South Wales (2)
Pennsylvania (2) Georgia (1) Queensland (1) Québec (1) Shang Hai Shi (1) Shanghai (1) Stockholm County (1)
La Jolla (72) New York (28) Seattle (16) Singapore (9) Tiffin (4) Champaign (3)
Camperdown (2) Los Angeles (2) Pittsburgh (2) Santa Barbara (2) Athens (1) Chicago (1) Evanston (1) Huddinge (1) Montréal (1) Saint Lucia (1) Shanghai (1)
Medicine (86) Science (24) Business (16) Engineering (10) Arts (9) Other (3)
Professor (84) Assistant Professor (31) Lecturer (19) Associate Professor (6) Researcher (2) Postdoctoral Fellow (1)
Faculty - Medicine - Other Medicine (78) Faculty - Business - Management (8) Faculty - Business - Other Business (6) Faculty - Health Sciences - Other Health Sciences (6) Faculty - Engineering - Chemical (4) Faculty - Medicine - Pharmacy and Pharmacology (4)
Faculty - Science (4) Faculty - Business - Finance (3) Faculty - Business - Marketing and Sales (3) Faculty - Education (3) Faculty - Engineering - Other Engineering (3) Faculty - Science - Computer Science (3) Faculty - Business (2) Faculty - Fine and Applied Arts - Other Fine and Applied Arts (2) Faculty - Health Sciences - Public and Environmental Health (2) Faculty - Medicine (2) Faculty - Medicine - Dentistry (2) Faculty - Science - Library and Information Science (2) Faculty - Science - Other Science (2) Faculty - Agriculture - Food Science (1)
Refine by Salary Range in USD
$75,000 - $100,000 (1) $100,000 - $150,000 (1)
University of California, San Diego (73) New York University (NYU) (30) University of Washington (16) Nanyang Technological University, Singapore (9) Heidelberg University (4) University of Illinois at Urbana-Champaign (3)
University of California, Los Angeles (2) Carnegie Mellon University (2) The University of Sydney (2) University of Chicago (1) University College London UCL (1) Northwestern University (1) Georgia Institute of Technology (1) McGill University (1) Karolinska Institute (1) The University of Queensland (1)
McGill University McGill University, Sherbrooke Street West, Montreal, QC, Canada
Sherbrooke 550 Part time JR0000034107  Please refer to the How to Apply for a Job (for External Candidates) job aid for instructions on how to apply. If you are an active McGill employee (ie: currently in an active contract or position at McGill University), do not apply through this Career Site. Login to your McGill Workday account and apply to this posting using the Find Jobs report (type Find Jobs in the search bar). Adjunct Professor in the School of Social Work, Faculty of Arts. This is an Unranked appointment as a member of the Contract Academic Staff and does not confer eligibility for tenure. As part of your appointment in the School of Social Work, you are expected to collaborate with the School through the engagement with 1) Indigenous access McGill; 2) the School's Nunavik initiative; and 3) the Indigenous field course (IDEF 500). Your appointment will be for three years, commencing November 1st 2022 and ending October 31st 2025. This...
NTU Main Campus, Singapore Part time R00012399 Responsibilities Facilitate learning environment for both under- and post-graduates Conduct lectures & tutorials where assigned Collaborate on research projects with faculty of the school Co-supervise post-graduate students Requirements Hold position in leading industrial or research environment Have relevant professional and/or teaching experience Possess a relevant PhD degree
locations NTU Main Campus, Singapore time type Part time posted on Posted 30+ Days Ago job requisition id R00011204 Duties to be assigned are subject to mutual agreement between you and the Chair, School of Physical and Mathematical Sciences. The work assigned will be up to an average of 8 hours per week. Hiring Institution: NTU In line with Singapore's nationwide Vaccination-Differentiated Safe Management Measures (VDS), employees must be fully vaccinated to return to the workplace, unless certified to be medically ineligible. For Information on VDS, please click here.
Adjunct Professor (Writing Consultant), Department of Undergraduate Academics, General Engineering (First-Year Engineering Program)
New York University (NYU) New York, NY, USA
Description The program in Undergraduate Academics at the NYU Tandon School of Engineering invites applications for adjunct faculty Writing Consultant positions in General Engineering, with a start date of January 23, 2023. New York University (NYU) is one of the top private universities in the United States. We have an illustrious past as Brooklyn Poly and NYU Polytechnic School of Engineering. Our mission is to excel in research, teaching and entrepreneurship. We aim to inspire and educate engineers for the 21st century. We are committed to quality, integrity, and respect for each other. We take pride in our high numbers of women students and students who are the first in their family to go to college. We seek faculty who have a real passion for a culturally diverse environment. We foster innovation and entrepreneurship that make a difference in the world: Our faculty and students are part of the high-tech start-up culture in New York City...
Assistant, Associate or Full Professor (HS Clinical, Clinical X, Adjunct, In-Residence) Surgical Sciences
University of California, San Diego Santa Barbara, CA, USA
POSITION DESCRIPTION The Department of Surgery and Division of Surgical Sciences (https://medschool.ucsd.edu/som/surgery/divisions/Sciences/) at UC San Diego is committed to academic excellence and diversity within the faculty, staff and student body. We are seeking non-clinician faculty to join a highly interdisciplinary programmatic effort within UC San Diego's Department of Surgery, dedicated to advancing the detection and treatment of surgical diseases. The successful candidate(s) will be responsible for research and providing high quality training and teaching of undergraduate, graduate and residents. The successful candidate(s) will be expected to participate in university service. The appropriate series and appointment at the Assistant, Associate or Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided for your review: HS Clinical Professor -...
Assistant, Associate or Full Professor (HS Clin, Clin X, Adjunct, In-Residence) Neuroradiology
POSITION DESCRIPTION The Department of Radiology at UC San Diego (http://radiology.ucsd.edu) is committed to academic excellence and diversity within the faculty, staff, and student body and is seeking a fellowship-trained Neuroradiologist to join our faculty to teach medical students, fellows and residents. UC San Diego School of Medicine is ranked among the top research-intensive medical-school programs in the nation by US News & World Report. UC San Diego Health is the only academic health system serving San Diego across campuses in Hillcrest and La Jolla, including 2 TJC Comprehensive Stroke Centers, an NCI-designated Comprehensive Center, Level 1 Trauma/Burn Center, Level 4 Epilepsy Center, Level 3 NICU, and Center of Excellence for Parkinson's Disease. UC San Diego Department of Radiology is one of the most innovative and productive academic departments in the country, offering state-of the-art services for clinical and translational studies. The...
Assistant, Associate or Full Professor (HS Clin, Clin X, Adjunct, In-Residence) Chest Radiology
POSITION DESCRIPTION The Department of Radiology (http://radiology.ucsd.edu) is committed to academic excellence and diversity within the faculty, staff, and student body. Due to continued growth in the division of Cardiothoracic Radiology, the Department is seeking faculty radiologists in this subspecialty. Clinical responsibilities will include interpretation of all aspects of thoracic (radiographs, CT and MR) and cardiac imaging (CT and MR). In addition to clinical responsibilities, candidates are expected to teach and educate medical students, residents, and fellows as well as participate in multidisciplinary conferences. The appropriate series and appointment at the Assistant, Associate or Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided for your review: HS Clinical Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-278.pdf...
Associate or Full Professor (HS Clin, Clin X, In-Residence, Adjunct) Pediatric Hepatology and Liver Transplantation, Medical Director
POSITION DESCRIPTION The University of California (UC) in San Diego is committed to academic excellence and diversity within the faculty, staff, and student body. The Division of Gastroenterology, Hepatology and Nutrition in the Department of Pediatrics is currently in an exciting period of growth and expansion. As part of our ongoing pursuit of clinical, education, and research innovation, we are seeking to recruit a full-time Pediatric Gastroenterologist with specific expertise in pediatric hepatology and liver transplantation to be the Medical Director for Pediatric Hepatology and Liver Transplantation at Rady Children's Hospital and UC San Diego. The successful candidate will join our GI practice of 21 faculty and 4 nurse practitioners covering a major portion of Southern California, Nevada, and Arizona. Our pediatric hepatology and transplant programs are fully integrated with the corresponding adult programs at UC San Diego. The successful candidate will play a...
Assistant, Associate, or Full Professor (HS Clin, Clin X, In-Residence, Adjunct) Infectious Disease Academic Clinician/Physician Scientist
POSITION DESCRIPTION The University of California, San Diego (UCSD), The Department of Pediatrics (https://medschool.ucsd.edu/som/pediatrics) is committed to academic excellence and diversity within the faculty, staff, and student body and are seeking an academic clinician or a physician scientist to join the Division of Infectious Diseases and the Infectious Diseases subspecialty service at Rady Children's Hospital – San Diego. The Division of Infectious Diseases participates in clinical care, teaching, clinical and basic research as well as hospital epidemiology and infection control at Rady Children's Hospital-San Diego. The 505-bed non-profit pediatric-care teaching facility serves as a major regional tertiary care hospital for children and adolescents. It is the largest children's hospital on the west coast (based on admissions) and serves a diverse population of one million children for their medical and surgical care. The Division has excelled in every...
Assistant, Associate or Full Professor (HS Clin, Clin X, Adjunct, In-Res) Pediatric Endocrinologist
POSITION DESCRIPTION The University of California, San Diego (UCSD) is committed to academic excellence and diversity within the faculty, staff, and student body. The Department of Pediatrics (http://www.pediatrics.ucsd.edu) in the Division of Pediatric Endocrinology, and Rady Children's Hospital-San Diego, a Medical Foundation (http://www.rchsd.org) are recruiting Pediatric Endocrinologists. The successful candidates are expected to participate and/or lead in teaching, mentoring, research, or service toward building an equitable and diverse scholarly environment. The successful candidates will collaborate with divisional faculty and clinical and basic science investigators in other departments. The appropriate series and appointment at the Assistant, Associate, or Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided for your review: HS Clinical Professor -...
Assistant, Associate, or Full Professor (HS Clinical, Clinical X, Adjunct, In-Residence) Physiatrist
POSITION DESCRIPTION The Department of Orthopaedic Surgery within the School of Medicine at the University of California, San Diego (http://ortho.ucsd.edu/) is committed to academic excellence and diversity within the faculty, staff and student body and is seeking a highly qualified and energetic board certified/eligible physiatrist to complement our non-surgical Orthopaedic practice. The nonsurgical musculoskeletal service line of UC San Diego Orthopaedics is expanding, and the candidate would join other Physical Medicine and Rehabilitation and non-surgical physicians in the Orthopaedic Surgery Department. The candidates will be working together with multidisciplinary teams and Orthopaedic surgeons to maximize the nonsurgical care of patients at UC San Diego. Responsibilities include outpatient and procedural care, with potential opportunities to provide inpatient care, as available. Position will assist with teaching, and will have opportunities for basic science...
Assistant, Associate, or Full Professor (HS Clinical, Clinical X, Adjunct, In-Residence) Orthopaedic Sports Medicine Physician
POSITION DESCRIPTION The Department of Orthopaedic Surgery within the School of Medicine at the University of California, San Diego (http://ortho.ucsd.edu/) is committed to academic excellence and diversity within the faculty, staff, and student body and is recruiting for an Orthopaedic Sports Medicine Physician. Responsibilities will include patient care, teaching, research at UC San Diego Health and team physician duties for local and university sports teams. The appropriate series and appointment at the Assistant, Associate or Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided for your review: HS Clinical Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-278.pdf Clinical X Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-275.pdf Adjunct Professor –...
Assistant, Associate or Full Professor (HS Clinical, Clinical X, Adjunct, In-Residence) Division Chief, Pediatric Ophthalmology
POSITION DESCRIPTION The Department of Ophthalmology at the University of California San Diego (http://health.ucsd.edu/specialties/eyes/Pages/default.aspx) is committed to academic excellence and diversity within the faculty, staff, and student body and is seeking an experienced, nationally recognized, dynamic and visionary leader to serve as the Division Chief of Pediatric Ophthalmology. The UC San Diego Division of Pediatric Ophthalmology is among the busiest pediatric practices in the county. It serves the children of San Diego County at both the Rady Children's Hospital via the Rady Children's Health Network and the UC San Diego Ratner Children's Eye Center. The amalgamation of Rady and UCSD resources into one program represents an exciting and unique opportunity. The successful candidate will lead the Rady's division in clinical care at multiple sites, research, teaching and educational programs. The appropriate series and appointment at the Assistant,...
Assistant, Associate or Full Professor (HS Clin, Clinical X, Adjunct, In-Residence) Ophthalmology or Vision Research
POSITION DESCRIPTION The Viterbi Family Department of Ophthalmology at UC San Diego (https://medschool.ucsd.edu/som/ophthalmology/pages/default.aspx) is committed to academic excellence and diversity within the faculty, staff, and student body. The Viterbi Family Department of Ophthalmology and Shiley Eye Institute are expanding. We seek candidates who are interested in clinical, translational and research positions; teaching of students, residents, and fellows. The appropriate series and appointment at the Assistant, Associate of Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided for your review: HS Clinical Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-278.pdf Clinical X Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-275.pdf Adjunct Professor –...
Assistant, Associate or Full Professor (HS Clin, Clin X, Adjunct, In-Residence) Pediatric Ophthalmology
POSITION DESCRIPTION The Department of Ophthalmology at UC San Diego (http://health.ucsd.edu/specialties/eyes/Pages/default.aspx) is committed to academic excellence and diversity within the faculty, staff, and student body. The Department of Ophthalmology, Shiley Eye Center, UCSD Vision Research and Rady Children's Hospital are expanding. The Department is recruiting for a physician specializing in Pediatric Ophthalmology. This position will be an academic appointment with clinical, educational, teaching and research responsibilities. Clinically the candidate will contribute to a robust pediatric ophthalmology practice serving the children of San Diego at both the Rady Children's Hospital via the Rady Children's Health Network and the UC San Diego Ratner Children's Eye Center. The amalgamation of Rady and UCSD resources into one program represents an exciting and unique opportunity. The appropriate series and appointment at the Assistant,...
Assistant, Associate or Full Professor (HS Clinical, Clinical X, Adjunct, In-Residence) MED - Hematologist
POSITION DESCRIPTION The Division of Hematology/Oncology (https://medschool.ucsd.edu/som/medicine/) in the Department of Medicine and the Hemophilia and Thrombosis Treatment Center at the University of California San Diego are committed to academic excellence and diversity within the faculty, staff and student body. The Division is seeking a hematologist to further build and expand the multidisciplinary programs of the Department of Medicine and the Hemophilia Treatment Center. The Division is seeking candidates with an interest in clinical, basic science, or translational research and/or medical education involving hemostasis/thrombosis and who are committed to excellence in patient care. The successful candidate will continue to help expand the robust clinical, research and educational activities including teaching of the Division of Hematology/Oncology and the Hemophilia and Thrombosis Treatment Center. The appropriate series and appointment at the Assistant,...
Assistant, Associate or Full Professor (HS Clin, Clin X, In Residence, Adjunct) Genitourinary Oncology
POSITION DESCRIPTION The Division of Hematology/Oncology (http://med.ucsd.edu) in the Department of Medicine at University of California, San Diego is committed to academic excellence and diversity within the faculty, staff, and student body and is actively recruiting a clinical investigator in genitourinary oncology. The candidate will be expected to help further develop an outstanding clinical research program in genitourinary oncology. Individuals with a track record of successful clinical trials leadership, translational research, or outcomes research and with a commitment to excellence in patient care are encouraged to apply. The individual will participate in the clinical programs and educational activities including teaching of the Division. The appropriate series and appointment at the Assistant, Associate or Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided...
Assistant, Associate or Full Professor (HS Clin, Clin X, Adjunct, In-Residence) MED - Hepatology
POSITION DESCRIPTION Faculty Position in Gastroenterology. The Department of Medicine (http://med.ucsd.edu) at University of California, San Diego is committed to academic excellence and diversity within the faculty, staff, and student body. The Division of Gastroenterology is actively recruiting a physician scientist. Clinical and teaching responsibilities will include Hepatology, Transplant Hepatology and endoscopy. The appropriate series and appointment at the Assistant, Associate or Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided for your review: HS Clinical Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-278.pdf Clinical X Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-275.pdf Adjunct Professor – see: http://ucop.edu/academic-personnel-programs/_files/apm/apm-280.pdf...
Assistant, Associate or Full Professor (HS Clin, Clin X, Adjunct, In-Residence) MED - Gastroenterology
POSITION DESCRIPTION Faculty Position in Gastroenterology. The Department of Medicine at University of California, San Diego, Department of Medicine (http://med.ucsd.edu/) is committed to academic excellence and diversity within the faculty, staff, and student body and is actively recruiting faculty with an interest in academia in the Division of Gastroenterology. Clinical and teaching responsibilities will include general gastroenterology. The appropriate series and appointment at the Assistant, Associate or Full Professor level will be based on the candidate's qualifications and experience. A link to full descriptions of each series is provided for your review: HS Clinical Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-278.pdf Clinical X Professor - see: http://www.ucop.edu/academic-personnel-programs/_files/apm/apm-275.pdf Adjunct Professor –...
Assistant, Associate or Full Professor (HS Clin, Clin X, Adjunct, In-Residence) - Hospital Medicine
POSITION DESCRIPTION ACADEMIC HOSPITALISTS AND NOCTURNISTS - The Division of Hospital Medicine, Department of Medicine, at the University of California, San Diego (http://med.ucsd.edu/) is committed to academic excellence and diversity within the faculty, staff, and student body and is recruiting full or part time Academic Nocturnists and Hospitalists to join our diverse and dynamic group of 50 physicians. Hospitalists participate in teaching, quality improvement and faculty development. We are seeking physicians trained in Internal Medicine committed to delivering excellent patient care, often integrated with regular medical student and resident educational opportunities, and participation in meaningful quality improvement efforts. Faculty development in most of these areas is available. The appropriate series and appointment at the Assistant, Associate or Full Professor level will be based on the candidate's qualifications and experience. A link to full...

redpajama_set_name: RedPajamaCommonCrawl


text:
Belfast City Council
Belfast car parking for new residential areas "a bad joke"
Stormont department approved 40 car parking spaces for a block of 270 apartments in city centre
Michael KenwoodLocal democracy reporter
Havelock House (Image: Google)
A Belfast Councillor has told a Stormont official the car parking provision for new residential areas in the city is "a bad joke."
At a special meeting of the council's City Growth and Regeneration Committee this week, Council members grilled officials from the Roads Division of the Department for Infrastructure on the amount of parking being provided for new residential developments.
DUP Councillor David Brooks told Kevin Monaghan, the DFI Divisional Roads Manager: "There are areas across the city we know to have significant parking difficulties. I don't think anyone would be surprised, or contest it, when I took the Markets or Donegall Pass as instances of areas that are troubled by commuter parking issues. Sandy Row also.
"Yet whenever we have, as a Planning Committee, advice from DFI around traffic and parking issues in an area, where there may be a development of several hundred dwellings or an apartment block being built, we are given single or double figure parking spaces.
New 19 storey apartment block approved by Belfast City Council
Plan to demolish former UTV building for apartment block rejected after wave of local complaints
"I recognise the aspirations of both this council and the DFI on sustainable travel. But I feel strongly, and I think the public agrees, that it should not be at the expense of local residents, who have to put up with parking in their areas."
The matter was raised after a plan to demolish Havelock House, the former UTV building, to build an apartment block on Belfast's Ormeau Road was rejected last week at the Belfast Council Planning Committee. Councillors argued inner city communities were being "squeezed out" by developers.
One of the main criticisms of the plan by councillors was that only 40 car parking spaces were allocated for 270 apartments. Numerous elected members at the committee said nearby residential areas would suffer the brunt of car parking requirements for the planned apartments.
How leisure centres across Northern Ireland will be impacted by the two week lockdown
Coronavirus restrictions: Belfast City Council to close Zoo and St George's Market for two weeks
Councillors criticised DFI Roads for green lighting the car parking arrangements for the proposal, but were advised by council officers that the plan could not be rejected on the basis of the car parking allocation. In the end the plan was rejected on the grounds of its scale and massing, and its potential effects on nearby listed buildings.
This week Councillor Brooks asked the department official: "How do DFI assess these parking issues? Because we are often told there are no issues with parking in an area after DFI assessment.
"I don't think aspirations should allow us to forget problems that exist within the city, particularly when it pertains to very significant planning decisions made by this council."
He added the "continuing lack of concern by DFI Roads has become a bit of a bad joke, I am afraid to say, amongst the planning members."
Kevin Monaghan replied: "You have asked a very difficult question. We are all about assessing access, movement and parking when it comes to roads and transportation infrastructure.
"However we don't make it up as we go along. There are a number of policy and guidance notes which we have to apply with every planning application that comes in. It is not a case of saying there is not a parking problem. Our officers are probably saying that the proposals comply with the current policy guidance that is across Belfast."
He said the Belfast Metropolitan Area Plan, a framework for land use in Greater Belfast, was in the process of being reviewed.
He said: "The city centre is a zone of restricted parking and that means basically there is only a small amount of parking for nearly every development."
He added: "With that said, parking is a big problem across Northern Ireland and in particular across Belfast. I think the answer lies in better public transport, cycling and walking infrastructure, which we are in the process of delivering."
Ormeau Road
South Belfast


View cart "Freedom Found" has been added to your cart.
What was it like to be married to Scotland's most famous prisoner?
Sara Trevelyan graduated as a medical doctor in 1977 at St Thomas's Hospital in London. She married Jimmy Boyle when he was an inmate in the Barlinnie Special Unit in 1980. After working in hospitals and medicine briefly, she left to explore mental health in the community, conducting an action research project for the Scottish Association for Mental Health. She was the co-founder and director of The Gateway Exchange in Edinburgh for eight years and for the past twenty-seven years has worked as a self employed counsellor and psychotherapist. Sara lives and works between Edinburgh and Findhorn.
Like Sara's official Facebook page.


text:
Jussie Smollett is returning to Empire for season 6, says co-star Taraji P Henson
"I haven't heard anything else."
By Dan Seddon
Shareif ZiyadatGetty Images
Empire star Taraji P Henson has revealed that Jussie Smollett will be in the show's sixth season.
Smollett – who portrays Jamal Lyon in the Fox series – faced a tsunami of controversy earlier this year after he was indicted on 16 felony counts in Chicago and accused of staging a racial and homophobic attack.
The actor and his attorneys maintained his innocence and he personally denied staging the incident, before all charges against the actor were then dropped last month.
His role in Empire had previously been cast into doubt, with whispers of a replacement doing the rounds.
However, while appearing on The View recently, Henson (who plays Jamal's mum Cookie Lyon on the series) discussed her co-star's situation and her hopes for the next season.
"I talk to Jussie all the time, he's doing well. Yeah, we're all doing well, the show is doing well, we're on hiatus right now, the writers are trying to figure out what the next season is going to look like; what our storyline is going to be.
Empire creator Lee teases gay superhero movie
"They're trying to drum up some really good juicy stuff for you guys, so that's where we are right now."
When pressed on whether Smollett is set to reprise his character for season 6, the actress simply added: "Yes, I haven't heard anything else."
Nuccio DiNuzzoGetty Images
Empire showrunner Brett Mahoney addressed the star's future on the show before the charges were dropped, noting at the time that it was "too early to think about what we would have to do if we didn't have Jussie".
He continued: "We have such a strong ensemble and we have so many stories to tell for all of these fascinating characters that it's bigger than one character, but it's too early to think about the show without him."
Empire airs on Fox in the US.
Want up-to-the-minute entertainment news and features? Just hit 'Like' on our Digital Spy Facebook page and 'Follow' on our @digitalspy Instagram and Twitter account.
Taraji P Henson on 'Person of Interest'
Empire star reprising role for spin-off series
Empire will return – with a change for Smollett
Taraji P Henson: 'Tom Hanks is down to earth'
Empire boss speaks out on Smollett return rumours
How will Jussie Smollett feature in season 6?


All sales are final. Tours occur rain or shine. Thank you!
Come experience what makes these 4 happy hours the best in Delray Beach!
6+ Food tastings 4 Cocktail tastings – with vendor demonstrations and much more! Tourists and locals are welcome!
Experience the buzz surrounding Delray Beach and its bustling Night life first hand by checking out 4 local gems.
Meet the restaurant staff, bartenders & chefs that have helped shape the Atlantic Avenue culinary scene.
What is a CRAFT Food Tour?
CRAFT's walking food tour provides its guests the opportunity to experience the most creative and inspired food and drink that South Florida has to offer. CRAFT Food Tours focuses on providing tastings that include locally sourced ingredients and are representative of the unique blend of culture and spontaneity that the Delray Beach community embodies. You will spend the day walking Delray Beach's vibrant Atlantic Avenue strip, making frequent stops in some of the staples of the neighborhood's restaurant scene to speak with chefs and mixologists alike about what goes into the dishes and craft cocktails that you will get to enjoy.
Escape the tourist areas and EAT & DRINK LIKE A LOCAL!
* Each tour is unique as destinations rotate according to restaurant availability. We visit 4 per Happy Hour Tour.
Nestled in a historic Delray Beach bungalow, Corner Porch's small plates and wonderful atomosphere will have you coming back for more.
New Cocktail Bar nestled in the 1925 historic Falcon House of Delray Beach.
Eclectic cocktail bar serving up some of the most unique mixed drinks in the #1 Rated Hotel in Downtown Delray Beach.
Neighborhood restaurant focusing on farm fresh ingredients, scratch kitchen, craft beers, seasonal cocktails and small production wines.
Upscale Latin American food that continues to exceed expecations of all its guests.
Self serve Craft Beer Bar where they take their food as serious as their beer.
Locally sourced New American fare & cocktails served in a stylish spot with an open kitchen & outdoor seating.
Bar 104 located inside Hyatt Place Delray Beach.
The tours are held rain, shine, or snow (haha). In the event of terrible weather, we will be able to go inside many of the establishments on the tour. We also provide ponchos in case of sudden weather changes or if you do not have your own umbrella. However, we advise to check the weather conditions for your days event and dress appropriately.
The tour includes 1 mile of easy walking over a 3 hour period with plenty of air-conditioned stops and 4 seated tastings. Our longest walk without stopping is 3 blocks.
Gratuities are greatly appreciated, although not mandatory. The standard gratuity in the service industry is 15%-20%. Tips for the establishments you will be visiting are included in the ticket price.
Come eat and sip on the most creative and inspired craft food and drink that South Florida has to offer! Plenty of Food & Drink for Lunch!
Escape the South Florida tourist traps as your local guides take you through the REAL Hollywood, Florida for an afternoon of Food and Drink!
Our 'Progressive Dinner' Tour is a walking guided dinner party where a 3-course food & drink pairing is enjoyed at 3 different restaurants.


text:
Man charged with sexual assault at Rochester hotel stands trial
By Christina J. Cleaver	 Last updated Dec 2, 2021
Rochester, MN (KROC-AM News) – An arrest warrant has been issued for a homeless man after he failed to appear for trial in Olmsted County Court on charges arising from an attack on a woman at a Rochester hotel in August.
Deonte Jenkins, 40, faces aggravated first-degree theft, second-degree criminal sexual behavior and first-degree burglary charges for allegedly forcing the 34-year-old victim back to her hotel room after confronting her in a stairwell and indicating that he had a gun. The woman told police that she was held against her will in the hotel room for more than nine hours, from the afternoon of August 27 to the early morning of August 28.
photo by Andy Brownell / TSM
Meanwhile, Jenkins allegedly sexually assaulted and stole the woman. She told investigators he threatened her, saying he had friends in the area who would kill her and her family if she contacted the police. Court records indicate that Jenkins was then located and arrested in downtown Rochester. He told police he had recently moved from Atlanta to the city.
His trial was due to open on Monday and the arrest warrant against him was issued on Tuesday. He was released from Olmsted County Jail in October after posting a $ 20,000 bond, which was forfeited after he failed to appear for a preliminary hearing last month.
Mayo Clinic doctor pleads not guilty to child sexual assault charges
See the Minnesota home that received 133 posting requests in less than 24 hours
There is a home for sale in Bloomington, Minnesota that received 133 requests within 24 hours of it being put on the market. It shows how crazy the housing market is right now, but this house is also gorgeous.
Ovolo Group is in the year of vegetables
Jupiter hotel in Portland will remain a homeless shelter
Eye on Travel – Hotel Du Pont in Wilmington, Delaware – June 19, 2021
Potential Stockton Inn buyer abandons plans for 780-seat theater and hotel
Online mortgage start-up lays off 9% of its staff, or around 900, as IPO approaches
Hampton Inn in Marina nears completion in Spring 2022 – Monterey Herald
Union Hotel and Union Hall
Richie Furay to perform at the Stanley Hotel Concert Hall
Oliver Kuhn has been appointed General Manager of Kempinski Hotel Moika 22, St.…


For starters, this system will likely include courses on community engagement and active citizenship. In order to pursue a piece of paper as a pharmacy technician and pass your exams you might address your inquiry for the Pharmacy Technician Certification Board (PTCB) along with the Institute of Certification of Pharmacy Technicians (ICPT). Experts have demostrated family history won't play a huge part in developing the disease.
If you're interested in certification to increase your career potential being a Georgia pharmacy tech, then read the Pharmacy Technician Certification Board certification program. My heart ached for the kids because their doctors were only hurting them by increasing their dosages and allowing them to become so influenced by drugs. You can place your order online from the comfort of your home.
Residencies really are a continuance of the pharmacy education set in a facility having a main preceptor and a lot of assistant preceptors inside facility. Don't believe that you have no access to fresh medicinal herbs. These online drug dealers bypass government safeguards that require uniformity of quality, a prescription coming from a licensed doctor saying the drug is intended particularly in your case, and the drug just isn't counterfeit, meets manufacturing standards and is also safe and effective to the prescribed use.
Also, look to the bargain table at the front of the store packed with items approximately 50 percent off the regular price. The holding, the transfers, the brand new rules and also the mail-order requirements. An person that finds work with this profession can certainly be a radiology technician if his competency qualifies him to perform work using x-ray, ultra-sound, CAT or ECG equipment providing you with the doctors with scanned images that the latter make use of as bases for his or her diagnoses.
A reputable company such as Canada Drug Center won't ever divulge your private data to anyone else. Review of the online pharmacy site is one from the best solutions to know which you could buy drugs safely and effortlessly. Homeopathy medicine may be around for many years.


The blocklists here are provided for free as part of the fight against malware.
However, it i's time to pay hosting costs once again….
Please help to keep this site free! Donate whatever you can, all donations go to hosting and infrastructure costs.
Support us in the fight against malware!
It's been two years running MalwareDomains.com as it's own separate domain. The blocklists here are provided for free for non-commercial use as part of the fight against malware.
However, it's time to pay hosting costs once again….
Over 325 new domains added – no many to list. We usually don't add spam or phishing domains due to their sheer number but this is an exception.
Check the http://www.malwaredomains.com/updates/20091017.txt file for the full list.
yak.com.pl (cleaned up site) and gamecentersolution.com (false positive) have been delisted and will be removed on the next update. Please remove from your blocklists.


Summer 2016 I was faced with the intimidating prospect of having to take the GAMSAT in order to realise my dreams. The more I read about GAMSAT, the more nervous I felt.
But not one to give up easily (thanks for passing that trait down to me, mum!) I researched the best preparation strategy and study materials.
It didn't take long for me to see that not only is the test itself expensive, but many GAMSAT study materials are too.
Now on the other side of the gruelling slog that is GAMSAT, I'm excited to share with you FREE high quality resources you can use to boost your score. I use these with students that I tutor.
Find these resources helpful? Have some feedback? Leave a comment below.
Need more help? We offer private GAMSAT tuition online and face-to-face.
To get new GAMSAT tips and free resources in your email inbox, subscribe to our mailing list.
You might also be interested in our articles 3 Excellent GAMSAT Study Materials and 4 Handy GAMSAT Section 3 Science Reasoning Skills.
Need more help? We offer private GAMSAT tuition.


Kailash Mansarover is considered to be the most wonderful spot on earth. Such a spot where God might want to live himself! Eccentrically, in four unique religions, Kailash Mansarovar, named after two heavenly goals Mount Kailash (standing tall at 21,778 ft.) and 'The Jewel of Tibet' – Lake Mansarovar, is viewed as the home Lord Shiva and other divine creatures.
According to the Hindu mythology, Lord Shiva is famous to live at Mount Kailash, as it is the sacred focus and a sign of glory. As indicated by Jainism, Mount Kailash, likewise perceived at Mount Ashtapada, is where the originator of the religion, Rishabhanatha attained self-determination or 'Nirvana'. Besides, Demchok Buddhists trust Kailash Mansarovar to be an image of agreement. At long last, as indicated by the Bon religion of Tibet, Mount Kailash is respected to be an establishment of profound power.
Buddhists trust that Lake Mansarovar is synonymous with Lake Anavatapta, where Maya imagined Gautam Buddha. It is additionally vital to Buddhist writing and lessons, as Buddha spent numerous years reflecting by the lake.
A noteworthy feature of Kailash Mansarovar Yatra is only 20 kms away. The significant (4500 m) freshwater, unadulterated, faultless and blue, Lake Mansarovar. It is trusted that the turquoise lake was first framed in the brain of Lord Brahma where later Lord Shiva and Lord Brahma showed up here as swans. The sacred water of Lake Mansarovar is said to have the intensity of washing without end our transgressions. In this way, circumambulating Mount Kailash can cancel bad behaviors.
In any case, imagine a scenario in which we revealed to you that there is a spot to do the majority of this, and that's just the beginning. The Kailash Mansarovar Yatra is a profound adventure like no other, transporting you appropriate to the entryway of paradise itself.
Lake Mansarovar otherwise called Mapam Yumtso is situated at the base of Mount Kailash at a height of 14, 950 feet and is viewed as the most astounding freshwater body on the planet. The name "Manasa sarovaram" in Sanskrit is a mix of the words for "psyche" and "lake".
Bons trust that the lake is synonymous with the hallowed god, Zhang Zhung Meri. It is additionally trusted that the originator of the Bon religion, Tonpa Shenrab, washed himself in the lake after first touching base in Tibet.
Jains trust that the lake is synonymous with Rishabhadeva, the first Tirthankara of Jainism.
Many intriguing legends encompass this blessed mountain and lake. You may connect with one or all, as you leave on your journey. Through the course of your adventure, you will start to see these legends come to fruition and structure. Your voyage will be more extravagant, your viewpoints more extensive.
It is trusted that Kailash Parikrama is tantamount to the existence cycle of an individual, so subsequent to finishing the Parikrama, one is renewed and turns into a totally extraordinary individual. Hindu's circumambulate in a clockwise way, though Buddhists do the voyage in an enemy of clockwise way. As per the legends, finishing 108 Parikramas would enable one to accomplish Nirvana and free him/her from the cycle of life and passing. A visit to the summit of this paradise on Earth is, truth be told, a strenuous, however compensating knowledge. Each traveler on this mind blowing venture experiences a lowering and edifying change, which must be appreciated on the off chance that you experience this Kailash Mansarovar Yatra, yourself.
The preeminent time the trip to Kailash Mansarovar and make the enchanting magnificence is amid the long stretches of May and June. September and October is additionally an exceptionally decent time to visit Kailash Mansarovar.


text:
<?php
namespace app\base\controller;
use framework\base\Controller;
class ErrorController extends Controller{

	public function error404($e=null){
		header('HTTP/1.1 404 Not Found');
		header("status: 404 Not Found");
		$this->error($e);
	}

	public function error($e=null){
		if( false!==stripos(get_class($e), 'Exception')  ){
			$this->errorMessage = $e->getMessage();
			$this->errorCode = $e->getCode();
			$this->errorFile = $e->getFile();
			$this->errorLine = $e->getLine();
			$this->trace = $e->getTrace();
		}

		//关闭调试或者是线上版本,不显示详细错误
		if( false==config('DEBUG') || 'production' == config('ENV') ){
			$home = new \app\home\controller\IndexController();
			$home->error404();
			//记录错误日志
		}else{
			$tpl = 'error_development';
			$this->display('app/base/view/error_development');
		}

	}
}

redpajama_set_name: RedPajamaGithub


Ferhan Sensoy (Nöbetci Tiyatro, 1997). Ferhan Sensoy's books, have been my best friend during my summer vacations as a teenager. When I was 14 I auditioned for his theater troupe and got accepted. His unique sense of humor and his loyalty to theater will always be an inspiration for me.


text:
Mashhadi Rajab returned from his field, holding his shovel that seemed as his rival in height. As he was cutting the miry land, he addressed his neighbour Ghulam Husayn:
"Mustafa Khan's canal will be digged toward our land tonight, it is inevitable to return at night for inspecting the water."
"I don't think so, they will dig it on the lower lands."
"Look at that multitude of people... I think someone is dead?"
"Hold your tongue, man... why do you croak like a crow. He is Imam Quli. He drew nigh and said: "What are you doing here? Are you from another world?" "What happened?"
"Al-Sayyid Muhammad Baqir al-'Isfahani, the cousin of the late Muhammad Ridha, is arriving today."
"Is he coming from Isfahan?" "No, from Najaf."
"Najaf!"
"Yes, I was informed so by Mirza Tahir. Both Karbala'i Taqi and al-Hajj 'Ali Jum'ah have gone for his reception, they may enter our village at any moment."
Looking far-away, he added: "Look, Qurban 'Ali has arrived. Send blessing upon the Prophet."
"You said that al-Sayyid Muhammad Baqir al-'Isfahani is to arrive, then you say: Qurban 'Ali has arrived! Send blessings upon the Prophet!"
"Don't you know that Qurban 'Ali was in Najaf to accompany al-Sayyid while coming here? O Mirza Kazim, chant for us, please."
Then Mirza Kazim started chanting and hymning with the blessings upon the Prophet and his Household. The space of the expansive fields was filled then with sweet heavenly melodies, adding to the splendidness of the village nice sunset.
Karbala'i Yahya said:
"O our master! Our village is divided into two parts separated by a line; the first part is called "Qanawat," and the second is "Behbahan"."
"You mean, there is a line separating them?"
Karbala'i Yahya, who was a short thin man, playing with his imbued beard, said: "No, Sir, there is a long alley separating them, that was named as line."
Mirza Tahir interferred interruptingly: "The late Mulla Muhammad Ridha has done his best to reconcile between the two parties, but was not respited by death (may Allah's mercy be upon him). On one of Ramadhan's evenings we sat till midnight, but... without reaching any conclusion, the Behbahan magnates stood up and departed the mosque."
Mashhadi Murad, while fixing his hood, said: "O Sir, the dispute is in origin about Mustafa Khan Canal... water is the basis of the trouble. If this problem was solved, no conflict would be there and concord would prevail."
Thereat Karbala'i regrettably said: "There is no sense in this dispute at all. We all belong to the same village, we are all Muslims and we and them are neighbours too. If the Sayyid permits us to invite both the parties to be present at Khayrabad School for a lunch banquet, and then we can decide what to do."
Muhammad Baqir, listening with regret, said:
"Allah - the Exalted - said: "And hold fast, all of you together to the cable of Allah, and do not separate." (3:103). And in another place of His Holy Book, He said: "The believers are naught else than brothers." (49:10).
Aren't these Allah's words? Hasn't Allah commanded us toward fraternity and evading dispute? I hope that harmony be prevailing and felicity be established, so that the Owner of Time (Sahib al-Zaman) be pleased with us, and Allah blesses us."
Imam Quli, addressing al-Sayyid Muhammad Baqir, said: "Some say that we should refer directly to the Imams' traditions (ahadith), applying all their precepts with no need to refer to a marji' taqlid (religious authority). That is, we have to imitate the Imams themselves with no need for any other person."
Muhammad Baqir was aware of the fact that the schools of the Akhbaris had its influence through these regions, so he said calmly:
"They are mistaken, how can we be sure of the veracity of these news, and that this was truly said by the Imams. As there are ahadith falsily ascribed to them, whose chain of transmission is weak, and some are contradictory to the Qur'an.
Who can differentiate between the scum from the good? Then there should be someone to undertake the task of investigating the narrations to recognize the weak and the authentic ones.
"This is the truth."
Al-Hajj Qurban 'Ali vainly said: "I remember I have said to one of them: If it be as you say, so it is not necessary to spend twenty or thirty years in learning and investigation at Najaf. As whoever is able to read and write can attain the position of giving fatwa (verdict), after reading some books containing the Imams' traditions and biographies!
... May Allah's mercy be upon Mulla Muhammad Ridha; his words were exactly like yours!"
Al-Hajj Ghulam Ridha, who sat beside the Sayyid, whispered: "Our master! According to your orders, I have invited all the men of Qanawat for having lunch."
"I seek God's forgiveness."
"I hope that all events be kept to their course, and concord prevails again... your coming is a blessing and grace for Behbahan."
Al-Hajj, addressing the banquet organizers, added: "O Mashad1 Mustafa! Don't leave the dish of broth in this corner. And you, O Husayn, tell them that yogurt is little, and don't forget to bring Karbala'i the dish of butter.
After all the guests had had their lunch, Imam Quli rose, saying: "Our master, let's go."
Addressing al-Hajj Ghulam Ridha, he added: "May Allah bless you, and shower mercy upon you. We seek your permission to go."
"Why are you in a hurry? Behbahan people wish the Sayyid stay among them, leading them in prayers, and guide them. O Karbala'i, you can stay too.
"Thank you, O Hajj, I have to go. But in regard of al-Sayyid, he can stay if he wishes."
Thus all the guests have left al-Hajj Ghulam Ridha's house, except al-Sayyid Muhammad Baqir who stayed in Behbahan.
We Seek Allah's Protection...
Khayrabad School seemed deserted as usual every Friday, with no one being there except Mashhadi Karam - the old school servant - who sat seeking warm under sun's ray of Adhar.2
Mirza Talib - a youth learning under al-Sayyid Muhammad Baqir - entered (the school) and saluted the old man.
The old man raised his head, gazing the young knowledge- seeker before replying: "And peace be upon you."
"They are still engaged in discussion, which has not ended since early morning till now. If you like to listen to their discussion, you can enter ... Murad 'Ali is there too."
Mirza Talib hesitated a bit before deciding to enter. Then he quietly opened the door, greeting his friends with low voice, and sat down listening to the conversation.
"We have reached the conclusion that non-other than the Book of Allah and the narrations reported from the Infallible Imams, can be a source for legislation. Even reason ('aql) cannot be a reliable source.
Al-Sayyid Muhammad Baqir was nodding his head while listening, then he raised his head saying: "Even if the case be explicit needing no proof, with no opinion related about it by the Prophet or the Imams. Or when adopting it being a common practice entailing that it has got concurrence of the Infallible Imams, what will be the ruling concerning this issue?"
"It will be rejected if not being supported by an authentic narration."
"Do you agree with what the linguists reiterate?"
"Is there any narration commanding you to do so?"
"Do you follow the recommendations and prescriptions of the doctor?"
"Which narration is there that obligates following the doctors' prescriptions? Certainly nothing of this sort can be there. This fact is not confined to the doctor, but it includes the architect, engineer, merchant and all other specialists.
Nevertheless we see people adopt their opinions, why? Because reason determines this, despite the absence of any tradition or Qur'anic verse in this respect.
A murmur prevailed among the Akhbaris present there. One of them commented by saying: "This man is a sophist .... he mixes between fiqh and construction."
Another one shouted: "He intends to extinguish the truth light by his debate."
A middle-aged man, wearing a black clock, stood up, saying: "Let's go, O friends! This man is giving reason an unparalleled status. I heard Mulla Husayn Quli say: When reason dictates that what contradicts the dictation of shar' (Islamic law), the dictate of reason will be prior to the dictate of shar' - we seek Allah's refuge. What a time is it?!"
Thus the Akhbaris left the place, afterwhich Mashhadi Murad entered holding sweet drink cups.
Mirza Talib asked: "O master, what were they saying?"
"I'll explain the matter for you later on, O son."
As al-Sayyid Muhammad Baqir was at the mosque, he
addressed Imam Quli thus:
"O Karbala'i! Tell people that today is the 1st of Shawwal, and we are going to establish feast prayer (Salat al-'Id)."
"But, our master, you informed us yesterday, that people should have daybreak meal and fast."
"Trustworthy men have testified the sighting of crescent (hilal) of the 'Id."
Karbala'i Imam Quli has ordered a number of youth to let people know about this. After a while, some people came carrying some dates and milk from the house of al-Hajj Ghulam Ridha al-Behbahani, for distributing them among the villagers who came to perform salat al-'id.
When the ceremonies of salat ended, one of the Akhbaris asked al-Sayyid Muhammad Baqir: "For which reason you have broken your fasting?"
"I became sure after ten trustworthy men gave witness." "Bring me a narration proving this, and your certainly is confined to a specific respect."
"It is really a regrettable matter, O brother! Though the narrations certify the confirmation of seeing the crescent with the testimony of two trustworthy men, you wonder about the tradition proving this!"
His speech was interrupted by al-Hajj Sharaf, addressing al- Sayyid: "I hope you accept my invitation to have lunch together. Do not forget to bring your family too."
"Peace be upon you, how are your Mirza Tahir? I was told that you are sick, so I came to visit you."
With a shivering voice, Mirza Tahir replied: "Praise belongs to Allah, our master. Days pass so fast, and no one of those accompanied you in your trip from Najaf, has survived except me. Years have elapsed like days ... thirty years have gone. Imam Quli died three years ago, al-Hajj Qurban 'Ali died in the last year, and it seems as it is my turn this time.
"O Mirza, what is that you utter? ... You will be well, God- willing."
"O Sayyid, I got tired. I have been bedridden for ten days, I cannot even move my hands. I have become a burden for the family."
"What does the physician say?"
"The physician is not a lord, the only thing he has is the "Taranjabin". Please invoke Allah to take away His trust, I am fed up with life. (His words were mixed with sobbing)."
"Allah is merciful O Mirza ... He is more merciful than the parents. Recovery is at His hand - the Glorified."
Then al-Sayyid Muhammad Baqir departed him, mumbling with supplication and prayers.
After elapse of several days, Mashhadi Muhsin came to inform the Sayyid about the passing away of Mirza Tahir, whereat the Sayyid rushed to his house for consoling his family.
"O 'Abd al-Husayn, see who is knocking at the door," said Sayyid Muhammad Baqir, calling his son.
'Abd al-Husayn rushed to open the door, then he said: "Father! It is a man asking about you."
The Sayyid stood up and went toward the door, saying: "Ma sha' Allah ... You and Behbahan?! You may have missed the way, please (come in)."
Sayyid Muhsin entered saying: O Allah .... O Allah." "Well O Sayyid! How are you?"
"You may forget your friends so soon, but I never forget."
"O Sayyid, I am engaged in some occupations. But tell me, O Sayyid Muhsin, why have you turned to be so old. Hoariness has invaded you and ...."
Sayyid Muhsin interrupted him with a smile: "But you haven't remained as young as you used to be when being a knowledge-seeker learning wisdom (hikmah) under al- Sayyid Muhammad.
"Yes, this is the nature of life, all have to go on a travel, ending with death.
"Yes, we are all on a travel. I have also thought with myself that when I will be asked about what I have done, what shall be my answer? When saying I was seeking knowledge, I shall be asked: What have you done with your knowledge? There at I will stand perplexed, so I have made up my mind to return to my town hoping for rendering a service that can be of benefit for me on the Reckoning Day.
"What an excellent opinion is it ... people are in need of men like you. When I was at Isfahan, I heard too much about you, people speaking of you constantly. I was told that some people at "Chahar Bagh3" School were saying that Sayyid Muhammad Baqir did a great job in guiding the Akhbaris to the right path.
"I seek Allah's forgiveness ... Muhammad Baqir is not in a position proper to guide people, Allah is the only One Who guides. He guides whoever He wishes, we are no more than mere means.
"Well, how could you manage to persuade them?
"They are truly good and simple people at the same time.
They are so fanatic for the Shari'ah (Islamic Law), the fact that caused them to slip, but when faced with a decisive argument they be convinced. They are of the opinion that it is not obligatory to imitate a mujtahid, and that imitation is confined only to the (Infallible) Imam, which is not possible; as deducing from reports can be done only by an expert man.
In the meantime, Muhammad 'Ali, the elder son of al-Sayyid Muhammad Baqir, entered holding cups of sweet drink and sweets (saying): "Peace be upon you."
"And upon you, Thanks to God, you have become elder.
A short period of silence prevailed, that was interrupted by Sayyid Muhammad Baqir's saying: "What news you have about Najaf?
"Everything is all right...but if you inquire about Karbala', I tell you it has turned to be a den for the Akhbaris, who believe in unlawfulness of learning usul al-fiqh.
"How amazing! I heard about this, but not to that extent.
"It is better, O Sayyid, that you send to Karbala' some copies of your book al-'Ijtihad wa al-'akhbar. They may be of benefit there."
"The book may be useful, but what is more important is struggling and combating at the battlefield. I wish I could go."
Thereat the call for noon prayer was raised, and Muhammad, Baqir stood up, saying: "I'll go to the mosque ... you can stay and rest." "Make yourself home, I will be back soon."
"I am going too, let's go together."
Then they both set out to the mosque.
"Praise belongs to Allah... Allah has showered upon you of His bounties."
"You haven't eaten well, O Sayyid! The food might be untasty."
"On the contrary, it was so good food, may the cook's hands be healthy."
Muhammad 'Ali whispered at his father's ears, while collecting the dishes.
"During your going to the mosque, Khayr Allah's wife came asking your attendance to marry her daughter to 'Abbas Quli Mirab."
"Have you noticed O Sayyid? People here badly need you; this 'Abbas Quli was married to his niece."
"It is impossible!!"
"When ignorance prevails among people, they do whatever they like. But I have given orders to their urgent separation (divorce)". "Did they respond?" "Yes, praise be Allah's."
"Praise be Allah's...and if they were of the opinion that imitating the mujtahid being unnecessary, they would have stuck to their foolish practices, everyone playing his drum." "Have you heard that one of the judges has ordered to bury a man returning from travel, after some people testified to the judge, during the man's absence, that he was dead? So the judge ordered to bury him as soon as he came back!"
"Have they buried him alive?!"
"Yes ... the judge has ordered to bury him, considering him dead according to the testimonies of the witnesses, and Shar' (Islamic Law) obligates the burial of the dead; so his burying is obligatery! Look, what have reports (akhbar) done to them!"
"For every field of knowledge there are its specialized men, and not whoever holds the plow becomes a farmer!"
"Even plowing and farming need one having expertise in these fields, being aware of their principles and ramifications (furu').
"I have to go back to Isfahan."
"What? Have you grown tired of us so soon?"
"I seek Allah's forgiveness."
"Spend your night here then... to travel in the morning is much better."
"What is the matter our master! Please stay with us."
Khwajah 'Aziz Kalantar4 was vainly insisting on al-Sayyid (to stay), but the latter never paid attention to him, and set out returning home.
Mashhadi Sha'ban Hamami said: The Sayyid may feel unwell, as he is not supposed to leave people without leading them in afternoon prayers (salat al-'asr).
Mirza5 Yahya al-'Attar rushed toward Khwajah 'Aziz: "Let him go, he may be sick ... why do you insist on him so much?"
Khwajah 'Aziz, a bit disturbed, said" "What do you say?"
Ghulam Ridha worriedly said: "You may have told him something that angered him."
"I said nothing (of that sort)."
"No, I saw you whispering at his ear."
"Nothing, I have just told him: Look what are the consequences of my orders? How have they led to mobilizing worshippers behind you?
Al-Hajj Ghulam Ridha exclaimed: "O Mulla Murad, go forward to lead afternoon prayer...people are awaiting".
Then he added, mumbling: "Khwajah 'Aziz has angered al-Sayyid by his words. Al- Sayyid is not like the others, who are pleased by multiplicity of people."
Then the call for prayer was raised by Mashhadi Sha'ban. In the evening (asil), Khwajah 'Aziz Kalantar set out, accompanied by al-Hajj Ghulam Ridha and some of the village dignitaries, toward the house of al-Sayyid Muhammad Baqir, for calling him to establish maghrib prayer at the mosque.
Al-Sayyid Muhammad Baqir quietly said: "Thanks to Allah, at Behbahan there is someone competent to substitute me in leading people in prayer and giving verdicts. I think my responsiblity has come to its end in this region, and I have to travel."
Khwajah 'Aziz sadly said: "O Sayyid, are you still angry with us?"
Al-Sayyid kindly replied: "Whatever happened has elapsed and it is finished with it. I determined to travel and returning to Najaf, the only thing I hope is you pray to Allah for me."
1. It is the abbreviation of Mashhad.
2. It is the ninth month of the Iranian calendar year.
3. Meaning the four gardens.
4. Meaning a police officer.
5. The Iranians give the tille "Mirza" to whoever is born of a mother belonging to Banu Hashim, not the father.


Thanks for checking out my blog and my first post! I am so excited to share this blog with you, as it will follow my experiences as a new mom, and hopefully it will help fellow new moms and give some humor to moms that have already been there and done that.
First off, this blog is not going to be about eating healthy, exercising, or using all organic products. I may mention some of that occasionally, but I just downed 6 cookies in one sitting, so at least the eating healthy part is out of the question. However, this blog WILL be about surviving parenthood any way that I can, and staying positive about it! I also like to dip into some crafts at times, when the baby is sleeping and I'm well rested and showered(maybe once a week) and I also like to read, travel, and hang out with my fur-children, so I'll be throwing in a little of those every now and then.
So far, in only 7 weeks and 2 days of parenthood, I have learned A TON. I had read a lot of blogs and pinned a thousand pins on Pinterest before I had my daughter, in hopes that I would be a parenting professional before I even became one. Well, I can tell you that I am definitely NOT a professional, and they really don't give you a manual. We were handed a baby with no instruction and we've kept it alive for 7 weeks so far, so I'd say we're making it! I have learned that not everyone does it the same way and you know your baby best. What works for me may not work for another mom, and vice versa.
My main goal in this blog is to spread positivity. Being a mom is not easy. I see SO many women on social media that have just had babies and their makeup is on, their hair is done, they look skinny (this one bothers me the most) and they appear to be wide awake. I realize that people use social media most of the time only to show their very best moments, but it gets to me, and I'm sure it gets to a lot of moms out there. I'm over here with no makeup, dried milk in my hair, and 15 extra pounds that just don't want to leave. To top that off, I'm SUPER grumpy because my sleep is always interrupted(my poor husband has to suffer). So it makes me feel like I'm not doing something right, and makes me question why I can't keep it together.
Well, I am here to tell you that you'll make it, mama! We're in this together. Even though we're tired, smelly, fat, and grumpy(and it's ok!) we are going to make it.
Good for you Nikinoo. You are a super good Mom – just like you are a super great person – always have been. Aubrey is so Blessed to have you and Josh-daddy.


text:
Buhari to MAN: we'll address FOREX supply issues
President Muhammadu Buhari has assured the Manufacturers Association of Nigeria (MAN) that the Federal Government would take appropriate measures to improve access to foreign exchange for importation of raw materials and machines that are not available locally.
The President spoke on Wednesday at the Presidential Villa, Abuja, during an advocacy visit of the leadership of MAN.
He told the executives of MAN that the relevant ministry would revisit their concerns about the increase in excise duties on the identified products and other tariff-related matters.
According to a statement by his Special Adviser on Media and Publicity, Femi Adesina, President Buhari also assured MAN that Nigeria will take steps to fully maximise the benefits of the African Continental Free Trade Area (AfCFTA).
The statement reads in part: ''Our strategic plan to boost manufacturing activities in the country is on course.
''We will continue to improve the patronage of locally made goods, bridge the gap between skills required by industry and those provided by our tertiary institutions and ensure seamless access to long term finance for our Small and Medium-Scale Enterprises (SMEs).
Read Also: CISLAC alleges intimidation by DSS operatives
''We recognise that MAN remains a key stakeholder in this journey and we will continue our engagement with you,.
''I beseech you to continue to support the government in our quest to provide the appropriate environment that will attract the necessary investment both domestic and foreign for the upliftment of the nation's economy."
On the impact of COVID-19 on world economies, the president noted that while the pandemic had an adverse impact on the Nigerian economy with the attendant fluctuations in the price of oil, his administration has effectively contained the spread of the pandemic and other diseases.
He added that the Federal Government would continue to consistently deploy prudent means of judiciously utilising the limited revenue to sustain the economy and stimulate growth.


A weapons physicist and his team has rescued and restored a plethora of deteriorating nuclear-test films and have uploaded them for everyone to enjoy. Around 750 have been declassified, and there is plenty more to come, as 6,500 films (out of an estimated 10,000) have been found. Check out the playlist for over 60 nuclear explosions.
The U.S. conducted 210 atmospheric nuclear tests between 1945 and 1962, with multiple cameras capturing each event at around 2,400 frames per second. But in the decades since, around 10,000 of these films sat idle, scattered across the country in high-security vaults. Not only were they gathering dust, the film material itself was slowly decomposing, bringing the data they contained to the brink of being lost forever. For the past five years, Lawrence Livermore National Laboratory (LLNL) weapon physicist Greg Spriggs and a crack team of film experts, archivists and software developers have been on a mission to hunt down, scan, reanalyze and declassify these decomposing films.